Publications by authors named "Jukka Auren"
Eur J Haematol
March 2008
Article Synopsis
- WT1 gene is overexpressed in most AML patients, but its reliability as a minimal residual disease (MRD) marker is questioned.
- In a study of 100 AML patients, median WT1 expression decreased significantly from diagnosis to remission, but many patients still showed elevated levels, complicating its utility in monitoring.
- Overall, the research suggests that WT1 gene expression lacks strong prognostic value and is only useful when more specific MRD markers are unavailable.
